Skip to main content

Serbian forward Luka Jovic reacts during the UEFA Europa League semi-final between Chelsea and Eintracht Frankfurt at Stamford Bridge in London on May 9, 2019.

BEN STANSALL/AFP/Getty Images

After a season without Cristiano Ronaldo and his goals, Real Madrid took a step toward filling that hole on Tuesday by signing Serbia forward Luka Jovic.

The 21-year-old Jovic, who scored 17 goals in 32 Bundesliga games for Eintracht Frankfurt last season, agreed to a six-year deal with Madrid – to be completed following a successful medical exam.

“A powerful forward with neat technique and an eye for goal, he is strong off both feet and his finishing is second to none,” Madrid said on its website.

Story continues below advertisement

Madrid-based sports daily Marca reported the club was paying 60 million euros ($67.5 million) with a bonus of 5 million euros ($5.6 million), with 30% of the transfer fee going to Benfica, Jovic’s former club.

Jovic moved to Benfica from Red Star Belgrade in January 2016 and joined Frankfurt on loan in 2017. He impressed mostly as a substitute under former coach Niko Kovac but excelled under successor Adi Hütter last season, prompting Frankfurt to take its option to make the loan permanent for a reported fee of about 10 million euros ($11.5 million).

Besides his 17 goals, five of which came in a 7-1 rout of Fortuna Duesseldorf in October, Jovic set up eight more and scored 10 goals in the Europa League – second only to Chelsea striker Olivier Giroud.

“From a sporting point of view, Luka Jovic is a huge loss for us,” Frankfurt chairman Fredi Bobic said. “But it was clear that every player has their price. It’s an important and good piece of transfer business for Eintracht Frankfurt.”

Jovic will compete with French forward Karim Benzema at Madrid, which also has forwards Gareth Bale, Lucas Vazquez, Mariano Diaz and Vinicius Junior.

The team struggled for goals last season following the departure of Ronaldo to Juventus.

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter